Revance Therapeutics | Marketskapitalisme

Market Capitalization Endring Dato
AbbVie USD 273.6B 10.51B 2023-12
ALKERMES USD 4.63B 36M 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Cara Therapeutics USD 41M 50M 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Merck USD 314.33B 38.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
P&G USD 381.45B 36.07B 2024-03
Pacira USD 1.33B 234M 2024-03
Revance Therapeutics USD 772M 237M 2023-12
Supernus Pharmaceuticals USD 1.89B 307M 2024-03



Revance Therapeutics Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.